Brasilia, Brazil – On October 30, WALTZ™ CoCr Coronary Stent System ("WALTZ™"), in-house developed by Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®"), received approval from Brazil's National Health Surveillance Agency (in Portuguese, Agência Nacional de Vigilância Sanitária - ANVISA). The product had received CE mark and gained regulatory approvals in Argentina, Peru, the Philippines, Indonesia, and etc.
WALTZ™ is indicated for the treatment of coronary artery stenosis or occlusion. It has L605 Cobalt-Chromium alloy stent architecture with three different stent designs. As the third-generation bare metal stent of MicroPort®, WALTZ™ has strong radial strength and excellent flexibility, crossability, trackability, and pushability to achieve the best surgical outcome.
Aside from WALTZ™, MicroPort®’s Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®"), Firefighter™ PTCA Balloon Dilatation Catheter ("Firefighter™ PTCA"), and other coronary interventional products also obtained regulatory approval in Brazil. As WALTZ™ is permitted to be officially launched in the Brazil market, MicroPort® will further diversify its cardiovascular product line with accelerated product upgrading. With its outstanding performance, WALTZ™ is expected to help MicroPort® further consolidate and expand its coronary products' market share in Brazil and other the overseas markets.
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.